Ozturk, E. Et Al. 2018. Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , vol.126, no.2 , 99-108.

Ozturk, E., Aksoy, S., Uğraş, N., Tunca, B., Ceylan, S., Tezcan, G., ... Yilmazlar, T.(2018). Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , vol.126, no.2, 99-108.

Ozturk, Ersin Et Al. "Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.," APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , vol.126, no.2, 99-108, 2018

Ozturk, Ersin Et Al. "Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.." APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , vol.126, no.2, pp.99-108, 2018

Ozturk, E. Et Al. (2018) . "Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.." APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , vol.126, no.2, pp.99-108.

@article{article, author={Ersin Ozturk Et Al. }, title={Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.}, journal={APMIS : acta pathologica, microbiologica, et immunologica Scandinavica}, year=2018, pages={99-108} }